Order Article Reprints

Zhang R, Chan K-H, Wang P, Zhou R, Yau HK-C, Wong CK-W, Au MW-L, Tam AR, Ng C-T, Lou MK-C, et al. A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults. Vaccines. 2023; 11(4):723. https://doi.org/10.3390/vaccines11040723

Zhang, Ruiqi, Kwok-Hung Chan, Pui Wang, Runhong Zhou, Henry Kwong-Chi Yau, Creany Ka-Wai Wong, Meena Wai-Lam Au, Anthony Raymond Tam, Chi-Tao Ng, Matthew Kwok-Chung Lou, and et al. 2023. "A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults" Vaccines 11, no. 4: 723. https://doi.org/10.3390/vaccines11040723

Zhang, R., Chan, K.-H., Wang, P., Zhou, R., Yau, H. K.-C., Wong, C. K.-W., Au, M. W.-L., Tam, A. R., Ng, C.-T., Lou, M. K.-C., Liu, N., Huang, H., Deng, S., Tam, R. C.-Y., Liu, Y., Long, T., Tsoi, H.-W., Ng, M. K. W., Cai, J.-P., ... Hung, I. F.-N. (2023). A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults. Vaccines, 11(4), 723. https://doi.org/10.3390/vaccines11040723